🇺🇸 FDA
Patent

US 11535851

Reagents for treatment of hepatitis B virus (HBV) infection and use thereof

granted A61KA61K31/513A61K31/522

Quick answer

US patent 11535851 (Reagents for treatment of hepatitis B virus (HBV) infection and use thereof) held by Benitec IP Holdings Inc. expires Mon Dec 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Benitec IP Holdings Inc.
Grant date
Tue Dec 27 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K31/513, A61K31/522, A61K31/675, A61K38/21